Depreciation of Avidity Biosciences, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Avidity Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Avidity Biosciences, Inc. Depreciation for the quarter ending 31 Dec 2025 was $1,466,000, a 99% increase year-over-year.
  • Avidity Biosciences, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $4,151,000, a 50% increase year-over-year.
  • Avidity Biosciences, Inc. annual Depreciation for 2025 was $4,151,000, a 50% increase from 2024.
  • Avidity Biosciences, Inc. annual Depreciation for 2024 was $2,776,000, a 32% increase from 2023.
  • Avidity Biosciences, Inc. annual Depreciation for 2023 was $2,101,000, a 51% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Avidity Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,151,000 $1,466,000 +$731,000 +99% 01 Oct 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 $3,420,000 $1,100,000 +$400,000 +57% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $3,020,000 $800,000 +$100,000 +14% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,920,000 $785,000 +$144,000 +22% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $2,776,000 $735,000 +$125,000 +20% 01 Oct 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 $2,651,000 $700,000 +$100,000 +17% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $2,551,000 $700,000 +$200,000 +40% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $2,351,000 $641,000 +$250,000 +64% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $2,101,000 $610,000 +$237,000 +64% 01 Oct 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
Q3 2023 $1,864,000 $600,000 +$200,000 +50% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $1,664,000 $500,000 +$200,000 +67% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $1,464,000 $391,000 +$77,000 +25% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $1,387,000 $373,000 +$142,000 +61% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $1,245,000 $400,000 +$200,000 +100% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $1,045,000 $300,000 +$200,000 +200% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $845,000 $314,000 +$206,000 +191% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $639,000 $231,000 +$141,000 +157% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $498,000 $200,000 +$100,000 +100% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $398,000 $100,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $398,000 $108,000 +$25,000 +30% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $373,000 $90,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $100,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $100,000 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $83,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1

Avidity Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,151,000 +$1,375,000 +50% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $2,776,000 +$675,000 +32% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $2,101,000 +$714,000 +51% 01 Jan 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
2022 $1,387,000 +$748,000 +117% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $639,000 +$266,000 +71% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $373,000 +$25,000 +7.2% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $348,000 -$35,000 -9.1% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $383,000 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.